<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="599" OLDID="12782" TOPICS="NO">
<DATE> 2-MAR-1987 13:12:43.17</DATE>
<TOPICS/>
<PLACES/>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f0459 reute
u f BC-EPITOPE-&lt;EPTO&gt;-SETS-T   03-02 0085</UNKNOWN>
<TEXT> 
<TITLE>EPITOPE &lt;EPTO&gt; SETS THREE FOR ONE STOCK SPLIT</TITLE>
<DATELINE>    BEAVERTON, Ore., March 2 - </DATELINE><BODY>Epitope Inc said its board of
directors has authorized a three-for-one common stock split for
which shareholder approval is expected in the next two weeks.
    The company announced a two-for-one split last week, but
said the board reconvened and agreed to change it to a
three-for-one split.
    Epitope is involved in the production of monoclonal
antibodies for diagnostic and therapeutic use in AIDS and other
immunological diseases.
 Reuter
 </BODY></TEXT>
</REUTERS>